News article

IMI2 Call 17 Now Open to Applications

22/01/2019

Over €80 million in funding for innovative open access tools for drug development, obesity, and the environmental impacts of medicines.

The Innovative Medicine Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). Through the IMI2 programme, IMI has a budget of €3.3 billion for the period 2014-2020.

Register to read full article